Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori

Dig Dis Sci. 2015 Oct;60(10):2901-12. doi: 10.1007/s10620-015-3712-y. Epub 2015 May 22.

Abstract

Helicobacter pylori (H. pylori) is one of the leading causes of gastric diseases such as chronic gastritis, peptic ulcer, and gastric adenocarcinoma. The current treatment of H. pylori infection with antibiotics and proton pump inhibitors has several limitations, including poor adherence and intrinsic patient-related factors, drug resistance, and the absence of adequate treatments. This review summarizes the current therapeutic approaches to eradicating H. pylori, the difficulties associated with its treatment, and several new perspectives aimed at improving existing treatment strategies.

Keywords: Gastric diseases; H. pylori eradication; H. pylori resistance; Helicobacter pylori; Treatment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenocarcinoma / prevention & control*
  • Anti-Bacterial Agents / administration & dosage
  • Drug Therapy, Combination
  • Female
  • Gastritis / drug therapy
  • Gastritis / etiology
  • Helicobacter Infections / complications*
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / isolation & purification
  • Humans
  • Male
  • Peptic Ulcer / drug therapy
  • Peptic Ulcer / etiology
  • Prognosis
  • Proton Pump Inhibitors / therapeutic use
  • Risk Assessment
  • Stomach Neoplasms / prevention & control*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Proton Pump Inhibitors